GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (FRA:6XB3) » Definitions » Balance Sheet Cash And Cash Equivalents

Biophytis (FRA:6XB3) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 2018. Start your Free Trial

What is Biophytis Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


Biophytis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (FRA:6XB3) » Definitions » Balance Sheet Cash And Cash Equivalents
Traded in Other Exchanges
Address
BC 9, Batiment A 4eme etage, 4 pace Jussieu, Sorbonne University, Paris, FRA, 75005
Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate BIO101, is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.